BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 30414957)

  • 1. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
    Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
    J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
    Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
    Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
    Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
    Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy.
    Fleshner K; Assel M; Benfante N; Lee J; Vickers A; Fine S; Carlsson S; Eastham J
    J Urol; 2016 Sep; 196(3):703-8. PubMed ID: 27049874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.
    Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J
    J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
    Wheeler TM; Dillioglugil O; Kattan MW; Arakawa A; Soh S; Suyama K; Ohori M; Scardino PT
    Hum Pathol; 1998 Aug; 29(8):856-62. PubMed ID: 9712429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods.
    Iremashvili V; Lokeshwar SD; Jorda M; Pelaez L; Soloway MS
    J Urol; 2013 Jul; 190(1):84-90. PubMed ID: 23246479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
    Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.
    Ristau BT; Tomaszewski JJ; Chen YF; Bertolet M; Woldemichael E; Nelson JB
    World J Urol; 2015 Sep; 33(9):1269-74. PubMed ID: 25366883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.
    Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ
    J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer polar localization on core biopsy predicts pathologic stage.
    Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
    Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted.
    Pierorazio PM; Epstein JI; Humphreys E; Han M; Walsh PC; Partin AW
    J Urol; 2010 Jan; 183(1):151-7. PubMed ID: 19914651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
    Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
    Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
    Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
    J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.